Truist Securities reiterates Buy rating on Xencor, $29 price target

Truist Securities reiterated their Buy rating on Xencor's stock with a price target of $29.00.The price target implies an upside of 21.8% from the Sep 25 close of $23.80.Key takeaways from the analyst noteEncouraging Clinical Data: Xencor's XmAb819 has demonstrated promising initial results in heav…